Clinical & translational oncology

• 

  Año 2013, Vol. 15, Número 9

  • Proteomic biomarkers in lung cancer

    María Dolores Pastor Herrera, A. Nogal, Sonia Molina Pinelo, Amancio Carnero, Luis Paz-Ares Rodríguez

    • Resumen

    págs. 671-672

    

  • Research opportunities in intraoperative radiation therapy: the next decade 2013�2023

    Felipe A. Calvo Manuel, C. Solé, Manuel González Domingo, E. D. Tangco, Juan López Tarjuelo, Youri Koubychine Merkulov, J. A. Santos, Javier Pascau, R. Herranz, Carlos Ferrer Albiach

    • Resumen

    págs. 683-690

    

  • Clinical and prognostic usefulness of serum proteomic profile in hepatic colorectal metastases: a pilot prospective study

    Josep Martí, José Fuster, J. M. Estanyol, F. Fernández, R. Deulofeu, Joana Ferrer, Amalia Pelegrina, A. Reyes, Constantino Fondevila Campo, Juan Carlos García-Valdecasas Salgado

    • Resumen

    págs. 691-697

    

  • Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC)

    Pablo Maroto Rey, Xavier García del Muro Solans, Begoña Mellado, José Luis Pérez Gracia, Raquel Andrés Conejero, Josefina Cruz Jurado, Enrique Gallardo-Díaz, Montserrat Domenech Santasusana, J. A. Arranz Arija, José Andrés Meana

    • Resumen

    págs. 698-704

    

  • Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer

    Alfredo Carrato Mena, A. Gómez, Pilar Escudero Emperador, Manuel Chaves Conde, Fernando Rivera Herrero, Eugenio Marcuello Gaspar, E. González Flores, Cristina Grávalos Castro, Manuel Constenla Figueiras, José Luis Manzano Mozo, Fernando Losa Gaspà, Joan Maurel Santasusana, R. Dueñas García, Bartomeu Massuti Sureda, Javier Gallego Plazas, Jorge Aparicio Urtasun, A. Antón Torres, Enrique Aranda Aguilar

    • Resumen

    págs. 705-711

    

  • Carnosol, radiation and melanoma: a translational possibility

    Miguel Alcaraz Baños, D. Achel, A. Olivares, E. Olmos, Miguel Alcaraz Saura, J. Castillo

    • Resumen

    págs. 712-719

    

  • Beam angle selection for intensity-modulated radiotherapy (IMRT) treatment of unresectable pancreatic cancer: are noncoplanar beam angles necessary?

    D. S. Chang, G. K. Bartlett, I. J. Das, Higinia Cárdenes

    • Resumen

    págs. 720-724

    

  • Management of malignant insulinoma

    Juan Carlos Ferrer García, Vega Iranzo González-Cruz, S. Navas, Miguel Civera Andrés, Carlos Morillas Ariño, Agustín Angel Merchante Alfaro, Cristina Caballero Díaz, Carlos Sánchez Juan, Carlos Camps Herrero

    • Resumen

    págs. 725-731

    

  • Defining prognostic factors of survival after external beam radiotherapy treatment of hepatocellular carcinoma with lymph node metastases

    Y.-X. Chen, Z.-C Zeng, J. Fan, Z.-Y. Tang, J. Zhou, M.-S. Zeng, J. Y. Zhang, J. Sun

    • Resumen

    págs. 732-740

    

  • Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression

    P. Liu, H. Liang, Q. Xia, P. Li, H. Kong, P. Lei, S. Wang, Z. Tu

    • Resumen

    págs. 741-746

    

  • Radiotherapy alone versus radiochemotherapy in patients with stage IIIA adenocarcinoma (ADC) of the lung

    Branislav Jeremic, Slobodan Milisavljevic, B. Milicic

    • Resumen

    págs. 747-753

    

  • Clinical target volume definition for glioblastoma radiotherapy planning: magnetic resonance imaging and computed tomography

    A. Fiorentino, R. Caivano, P. Pedicini, V. Fusco

    • Resumen

    págs. 754-758